Give Online: Help shape patient care for generations to come.


Request an Appointment

Cancer Answer Line:

M-F 8 a.m. - 4:30 p.m. ET

Expand Content

Cancer Clinical Trials Results

2559  Genetic and molecular analysis of tumors of the Nervous system and their coverings Main Campus  Brain
BRMY 1315 16-134 A Randomized Phase 3 Open Label Study of Nivolumab vs Temozolomide Each in Combination with Radiation Therapy in Newly Diagnosed Adult Subjects with Unmethylated MGMT (tumor O-6-methylguanine DNA methyltransferase) Glioblastoma Main Campus Phase 3Brain, Glioblastoma
CASE 1307296 Ohio Brain Tumor Study (OBTS) Main Campus  Brain
CASE 331313-445 A prospective phase II trial of NovoTTF-100A with Bevacizumab (Avastin) in Patients with Recurrent Glioblastoma Main Campus Phase 2Brain, Glioblastoma
CASE 731213-143 Neoadjuvant Radiosurgery for resectable brain metastases: Phase I/II Study Main Campus Phase 1, Phase 2Brain
CASE 7315 16-085 Targeting Myeloid Derived Suppressor Cells in Recurrent Glioblastoma: Phase 0/1 Trial of Low Dose Capecitabine + Bevacizumab in Patients with Recurrent Glioblastoma Main CampusRecurrent/RelapsedPhase 1Brain, Glioblastoma
CASE 831213-221 Dose Escalation for Larger Brain Metastases: Phase I/II Study Main Campus Phase 1, Phase 2Brain
INFT 1315 15-614 A Pilot Trial of Intraparenchymally-Administered Topotecan using Convection-Enhanced Delivery (CED) in Patients with Suspected Recurrent/Progressive WHO Grade III or IV (High Grade) Glioma Undergoing A Clinically-Indicated Surgical Resection (IND 117,240) Main Campus  Brain, Glioma
KDMN 1316 16-801 A Phase 2, Multicenter Study of Tesevatinib Monotherapy in Patients with Recurrent Glioblastoma Main CampusRecurrent/RelapsedPhase 2Brain, Glioblastoma
MONT 1316 16-688 Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN) Prospective Registry Main Campus  Brain
NCTG 1310CC00039; N0577 Phase III Intergroup Study of Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma Beachwood, Fairview, Hillcrest, Independence, Main Campus, Wooster Phase 3Brain
NEONC 1315 15-1645 An Open-Label Phase 1/2a Dose Escalation Study of Safety and Efficacy of NEO100 in Recurrent Grade IV Glioma Main CampusRecurrent/RelapsedPhase 1, Phase 2Brain, Glioma
NRG CC001 15-1581 A randomized phase III trial of Memantine and whole-brain radiotherapy with or without hippocampal avoidance in patients with brain metastases Fairview, Florida Weston, Hillcrest, Independence, Main Campus, North Coast Cancer, Strongsville, Wooster Phase 3Brain
RPCI 1315 15-536 A Phase II Study of the Safety and Efficacy of SVN53-67/M57-KLH (SurVaxM) in Survivin-Positive Newly Diagnosed Glioblastoma Main Campus Phase 2Brain, Glioblastoma
STML 131414-698 A Phase 1/2 Study of SL-701, a Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme Main Campus Phase 1, Phase 2Brain, Glioblastoma
TOG 1311CC00195 A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 Main Campus Phase 2Brain
TOG 1315 15-1301 A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With 0054oca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma Main Campus Phase 2, Phase 3Anaplastic Astrocytoma, Brain, Glioblastoma

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).


Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.